Pfizer Considers Relocating Overseas Manufacturing to US Facilities
15 Articles
15 Articles
Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US
"I was expecting him probably to win," Pfizer's CEO Albert Bourla said of President Donald Trump's election victory.Leigh Vogel via Getty Images; Carl Court via Getty ImagesPfizer's CEO said he may move manufacturing back to the US in response to Donald Trump's tariffs.Albert Bourla said he was not surprised by Trump's victory in November.Trump has threatened to impose tariffs on Mexico, Canada, and China.Albert Bourla, Pfizer's CEO, said on Mon…
Pfizer says more drugs can be made in its US plants for domestic market, if needed
Pfizer CEO Albert Bourla said on Monday that the drugmaker can shift manufacturing for the US market to its existing plants in the US, as the threat of tariffs puts a question mark over global supply chains.
Coverage Details
Bias Distribution
- 56% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage